Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) Clinical Trials
2 recruiting trials for Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by American Laboratory Products Company (1), University Hospital Tuebingen (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is ALPCO Calprotectin CLIA (device, 1 trial), followed by Biologic Agent.
Track Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
The ALPCO Calprotectin CLIA is an in vitro diagnostic test intended to quantitatively measure concentrations of fecal calprotectin in human stool samples. Calprotectin is a...
Molecular Inflammation Board at the Center for Personalized Medicine
Molecular Inflammation Board at the Center for Personalized Medicine
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.